tetano
Editor, Senior Moderator
Sci Rep
. 2024 Feb 20;14(1):4243.
doi: 10.1038/s41598-024-52748-3. Analysis of related factors for RA flares after SARS-CoV-2 infection: a retrospective study from patient survey
Rong Li[SUP] 1 [/SUP], Jun-Kang Zhao[SUP] 1 [/SUP], Qian Li[SUP] 1 [/SUP], Li Zhao[SUP] 1 [/SUP], Ya-Zhen Su[SUP] 1 [/SUP], Jun-Yan Zhang[SUP] 2 [/SUP], Li-Yun Zhang[SUP] 3 [/SUP]
Affiliations
SARS-CoV-2 and its variants are widely prevalent worldwide. With frequent secondary and breakthrough infections, immune dysfunction in RA patients, and long-term use of immune preparations, SARS-CoV-2 infection poses a significant challenge to patients and rheumatologists. Whether SARS-CoV-2 infection causes RA flares and what factors aggravate RA flares are poorly studied. A questionnaire survey was conducted on RA patients infected with SARS-CoV-2 after December 7, 2022, in China through a multicenter and inter-network platform regarding general personal condition, primary disease, comorbidity, SARS-CoV-2 vaccination, viral infection, and impact on the primary disease. A total of 306 RA patients were included in this study, and the patient data were analyzed, in which the general condition of RA patients, medication use before SARS-CoV-2 infection and post-infection typing and manifestations, and medication adjustment did not affect the Flare of RA patients after SARS-CoV-2 infection. The control of disease before SARS-CoV-2 infection (OR = 2.10), RA involving pulmonary lesions (OR = 2.28), and the recovery time of COVID-19 (OR = 2.50) were risk factors for RA flare. RA involving pulmonary lesions, control status of disease before infection, and recovery time of COVID-19 disease are risk factors for RA flare after SARS-CoV-2 infection.
. 2024 Feb 20;14(1):4243.
doi: 10.1038/s41598-024-52748-3. Analysis of related factors for RA flares after SARS-CoV-2 infection: a retrospective study from patient survey
Rong Li[SUP] 1 [/SUP], Jun-Kang Zhao[SUP] 1 [/SUP], Qian Li[SUP] 1 [/SUP], Li Zhao[SUP] 1 [/SUP], Ya-Zhen Su[SUP] 1 [/SUP], Jun-Yan Zhang[SUP] 2 [/SUP], Li-Yun Zhang[SUP] 3 [/SUP]
Affiliations
- PMID: 38378889
- PMCID: PMC10879520
- DOI: 10.1038/s41598-024-52748-3
SARS-CoV-2 and its variants are widely prevalent worldwide. With frequent secondary and breakthrough infections, immune dysfunction in RA patients, and long-term use of immune preparations, SARS-CoV-2 infection poses a significant challenge to patients and rheumatologists. Whether SARS-CoV-2 infection causes RA flares and what factors aggravate RA flares are poorly studied. A questionnaire survey was conducted on RA patients infected with SARS-CoV-2 after December 7, 2022, in China through a multicenter and inter-network platform regarding general personal condition, primary disease, comorbidity, SARS-CoV-2 vaccination, viral infection, and impact on the primary disease. A total of 306 RA patients were included in this study, and the patient data were analyzed, in which the general condition of RA patients, medication use before SARS-CoV-2 infection and post-infection typing and manifestations, and medication adjustment did not affect the Flare of RA patients after SARS-CoV-2 infection. The control of disease before SARS-CoV-2 infection (OR = 2.10), RA involving pulmonary lesions (OR = 2.28), and the recovery time of COVID-19 (OR = 2.50) were risk factors for RA flare. RA involving pulmonary lesions, control status of disease before infection, and recovery time of COVID-19 disease are risk factors for RA flare after SARS-CoV-2 infection.